Breast

Use of DiviTum -TKa as a biomarker assay for CDK4/6 inhibitor medication compliance and drug-drug interactions assessment and intervention in HR-positive metastatic breast cancer patients

Volunteers
Health Professionals

What is the purpose of this trial?

The purpose of this study is to assess optimal blood levels of this medication in the blood, and to assess medical compliance and drug-drug interactions.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Mariya Rozenblit

mariya.rozenblit@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Mariya Rozenblit, MD
Assistant Professor of Medicine (Medical Oncology)

Sub-Investigators

Last Updated
04/12/2024
Study HIC
#2000033797